Reuters reveals Buyout fund Ardian makes $1.2 bln swoop on Italy's Biofarma Group - Reuters News Agency

Reuters reveals Buyout fund Ardian makes $1.2 bln swoop on Italy’s Biofarma Group

Reuters broke the news that European private equity firm Ardian has clinched a deal to buy Italian drug firm Biofarma Group for about 1.1 billion euros ($1.26 billion) — its second pharmaceutical deal in less than a year. The transaction will see Ardian expanding in the lucrative dietary supplement market, an industry that has been booming during the COVID-19 pandemic as people have turned to multivitamin products to boost their immunity.

Article Tags
Topics of Interest: DealsHealth
Type: Reuters Best
Sectors: Business & FinancePharmaceuticals & Healthcare
Regions: Europe
Win Types: Speed
Media Types: Text
Customer Impact: Important Regional Story
Officers offload a box of Sinovac's vaccine for coronavirus disease (COVID-19) as it arrives at the cold room of Indonesia's local health department in Palembang, South Sumatra province, Indonesia, January 4, 2021 in this photo taken by Antara Foto.  Antara Foto/Nova Wahyudi/ via REUTERS  ATTENTION EDITORS - THIS IMAGE WAS PROVIDED BY A THIRD PARTY. MANDATORY CREDIT. INDONESIA OUT.
Sign up for email updates
Sign up for email updates